AestheticsFeatured ArticlesPsoriasisThe Latest

Psoriasis Clearance Motivates Patients to Seek Cometic Procedures, Study Finds

By January 28, 2021March 25th, 2021No Comments

Featured Article

Featured Article

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

More Psoriasis Articles

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

Heather Onorati

A significant reduction in psoriasis body surface area (BSA) may motivate patients to seek cosmetic procedures, according to findings from a recent study, “Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement.”

Patients with moderate to severe psoriasis who achieved 75% or greater reduction in BSA showed an increased uptake in cosmetic procedures and this increase correlated with a reported improvement in quality of life after psoriasis clearance, the authors found.

Researchers lead by Michelle Walters, M.D., Harbor-UCLA Medical Center, Torrance, Calif., examined the relationship between improvement in quality of life following a reduction in BSA and the use of cosmetic procedures. They identified 138 patients with a history of moderate to severe psoriasis from  the Dermatology Institute and Skin Cancer Center in Santa Monica, Calif., and surveyed them using the Dermatology Life Quality Index (DLQI), adding an additional 5 questions related to the patients’ cosmetic procedures.

Of the group, 119 patients said they had never before undergone a cosmetic procedure due to their psoriasis. All of the patients responded that their quality of life had improved with their psoriasis treatment, and the majority (91%) said this improvement motivated them to undergo the cosmetic procedure.

The most common cosmetic procedures sought by these patients were neurotoxins, soft tissue augmentation and chemical peels. In addition, 79% of the patients purchased skincare products dispensed through the office.

“The improvement in quality of life following treatment of psoriasis with systemic or biologic agents noted in our study reflects results from previous studies,” the authors note. However, the authors state that there have been no studies that have examined a correlation between the improvement in quality of life following psoriasis treatment and an uptake in surgical or nonsurgical cosmetic procedures.

“We found that a common motive for patients who sought cometic procedures was the desire to further improve their quality of life after clearance of their psoriasis,” the authors say. They add that this study indicates that successful treatment of the condition may be a motivator for patients to seek cosmetic procedures for other skin indications.

Heather Onorati is an experienced medical writer and editor with more than 20 years covering the dermatology industry

Discover new clinical findings in Psoriasis.  View the latest articles, case reports, supplements, CME activities, Podcast episodes and more.

 

You May Also Like

Year in Review: 2025 Highlights From JDD

| Featured Articles, Latest News | No Comments
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

| Featured Articles, Latest News, Rosacea, Women | No Comments
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…
Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

| Featured Articles, Latest News, Skin Cancer | No Comments
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…

Leave a Reply